Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Pyridone 6, A Pan-Janus–Activated Kinase Inhibitor, Induces Growth Inhibition of Multiple Myeloma Cells
2006
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.
1996
Human B cell precursors proliferate and express CD23 after CD40 ligation.
1993
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
2001
Molecular imaging in drug development
2008 Standout
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
CD44: From adhesion molecules to signalling regulators
2003 Standout
Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC)
2013 Standout
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Aminopeptidase A: A nephritogenic target antigen of nephrotoxic serum
2001
Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
2001
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice.
1996
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
1997
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments
2002
Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: Implications for prognosis and staging
2006
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Cell-surface enzymes in control of leukocyte trafficking
2005
Metabolism of amyloid-β peptide and Alzheimer's disease
2005
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
A Constant Light-Genetic Screen Identifies KISMET as a Regulator of Circadian Photoresponses
2009 StandoutNobel
The CD44 Proteins in Embryonic Development and in Cancer
1996
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Prostasome to sperm transfer of CD13/aminopeptidase N (EC 3.4.11.2)
1997
Systemic amyloidosis
2015 Standout
Matrix metalloproteinases as modulators of inflammation and innate immunity
2004 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes
1996
Inflammation and cancer: back to Virchow?
2001 Standout
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Aminopeptidase A Expression in Cervical Neoplasia and Its Relationship to Neoplastic Transformation and Progression
2000
Physiology of Local Renin-Angiotensin Systems
2006 Standout
p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas
2002
Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells
2002
HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation
2007
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Microarray Analysis and Organization of Circadian Gene Expression in Drosophila
2001 StandoutNobel
Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons
2011
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Organizing the cell cortex: the role of ERM proteins
2010 Standout
Getting to the site of inflammation: the leukocyte adhesion cascade updated
2007 Standout
Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?
1996
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
1998 StandoutNature
Morphine stimulates nitric oxide release from invertebrate microglia
1996
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1
2000
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Structural Basis for Type II Membrane Protein Binding by ERM Proteins Revealed by the Radixin-neutral Endopeptidase 24.11 (NEP) Complex
2007
Metalloproteinases Are Involved in Lipopolysaccharide– and Tumor Necrosis Factor-–Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression
1999
Expression of CD10 by Human T Cells That Undergo Apoptosis Both In Vitro and In Vivo
1999
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Exosomes
2019 Standout
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor
1995
CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane
2002
CD44 cell adhesion molecules.
1999
Revised Response Criteria for Malignant Lymphoma
2007 Standout
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
Forms and functions of CD44
1998
Murine B Cell Development: Commitment and Progression from Multipotential Progenitors to Mature B Lymphocytes
1995
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
2004
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
2002 Standout
The DrosophilaslamdanceGene: A Mutation in an Aminopeptidase Can Cause Seizure, Paralysis and Neuronal Failure
2002
Changes in monocytic expression of aminopeptidase N/CD13 after major trauma
2003
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
1997 Standout
Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2−and Systolic Blood Pressure in Mice
2001
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
2002
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.
1998
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
2000
In Vivo Antibody-mediated Modulation of Aminopeptidase A in Mouse Proximal Tubular Epithelial Cells
1999
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma
2001
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
A Directly Spliced Exon 10–Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma
1998
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
1998 Standout
Gene Selection for Cancer Classification using Support Vector Machines
2002 Standout
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
1997
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
1999
Physiology of Microglia
2011 Standout
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Peptide Targeting of Platinum Anti-Cancer Drugs
2009
Works of MA Shipp being referenced
Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!
1993
Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies
1993
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide- induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation
1991
Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies
1993
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src- related kinase
1996
CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src- related kinase
1996
Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele
1988
CD10/NEP is expressed on Thy-1low B220+ murine B-cell progenitors and functions to regulate stromal cell-dependent lymphopoiesis
1992
Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements
1995